Drug Warning

0
26

The Spanish Agency of Medicines and Health Products has issued a warning about a drug used to treat uterine fibroids. It recommends no new treatments using Esmya should begin until the drug is re-evaluated following reports of several serious cases of liver damage. The Agency says liver functions should be monitored every month in existing patients, and between two and four weeks after treatment ends.

SHARE
Previous articleAngels’ Arrest
Next articlePoints Record

LEAVE A REPLY

Please enter your comment!
Please enter your name here

This site uses Akismet to reduce spam. Learn how your comment data is processed.